drugset / Trial / NCT04725695

Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy

NCT04725695 ↗

Phase 4 Terminated 119 enrolled Bispebjerg Hospital
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

In this randomized placebo-controlled clinical trial, patients will be randomized to be administered viscous lidocaine or placebo preoperatively to elective upper GI endoscopy

Timeline

Start
2022-03-29
Primary completion
2023-12-15
Completion
2024-10-30

Outcome

Outcome not reported

Stopped: “Lack of ressources”

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 20 mg/ml Oral

Indications

No indication recorded.